Method for purifying single virus in multi-subtype avian influenza virus mixed infection
By using AIV hemagglutinin monoclonal antibody for specific neutralization experiments, the accuracy and efficiency of the purification of mixed infection samples of multi-subtype avian influenza viruses was solved, and efficient and accurate virus purification was achieved, reducing cost and time consumption. .
Patent Information
- Application Number
- CN202411357929.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-27
- Publication Date
- 2024-11-12
AI Technical Summary
The prior art is difficult to effectively purify mixed infection samples of multi-subtype avian influenza viruses, resulting in inaccurate purification results and high cost and time consumption, and cross-reaction problems for specific antibody serum.
AIV hemagglutinin monoclonal antibody was used to purify and identify mixed infected AIVs, and a specific neutralization experiment was conducted by replacing serum by monoclonal antibody to neutralize specific antigens in the viral solution, reducing the number of passages and preventing viral mutation.
The rapid purification of a single virus in the mixed infection of multiple subtype avian influenza viruses was achieved, which improved the accuracy and efficiency of the purification effect, reduced cost and time, avoided cross-reactions, and maintained the biological characteristics of the virus.
Smart Images

Figure CN118931849A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of avian influenza virus purification, and in particular to a method for purifying a single virus in a mixed infection of multiple subtypes of avian influenza viruses. Background Art
[0002] In recent years, people have paid unprecedented attention to the genetic variation mechanism, evolutionary epidemic trend and vaccine development and utilization of avian influenza viruses (AIVs). Obtaining a large number of purified AIVs epidemic strains is the premise and basis for carrying out these works, and it is also an important means to ensure the quality of work. In recent years, studies on the subtype distribution of AIVs in live poultry in Guangxi Zhuang Autonomous Region have found that it is very common for multiple subtypes of AIVs to co-infect the same poultry. How to simply and effectively separate and purify mixed-infected AIVs is a difficult problem that many avian influenza researchers must face.
[0003] Plaque purification is an effective approach, but its application in AIVs purification is restricted due to its high requirements for experimental conditions, cumbersome operation, and insufficient ability to process large quantities of samples. The chicken embryo limited endpoint dilution method is widely used because of its simple operation, low requirements for experimental conditions, and ability to process a large number of samples in parallel. However, due to the differences in the proliferation rate and competitive growth ability of multiple subtypes of AIVs in the same chicken embryo, often only a certain strain with competitive advantages can be purified, and other subtypes of AIVs are masked or lost, and the actual results of purification may not be consistent with the original intention. The chicken embryo endpoint dilution combined with specific antiserum neutralization method has good practicality, but the specific antibody serum used in it still has certain cross-reactions when used, resulting in unsatisfactory purification effects. AIV hemagglutinin monoclonal antibodies have strong specificity, which can effectively solve the problem of cross-reaction of antibody serum and realize the rapid purification of a single virus in mixed infection of multiple subtypes of avian influenza viruses. Summary of the invention
[0004] In order to solve the above technical problems, the present invention provides a method for purifying a single virus in a mixed infection of multiple subtypes of avian influenza viruses, using AIV hemagglutinin monoclonal antibodies to purify and identify the mixed infected AIVs, using monoclonal antibodies instead of serum to perform specific neutralization experiments, and at the same time, relatively quantitatively neutralizing specific antigens in the mixed virus solution, reducing the number of passages, and preventing the virus from mutating due to multiple passages.
[0005] To achieve the above purpose, the technical solution provided by the present invention is as follows:
[0006] A method for purifying a single virus in a mixed infection of multiple subtypes of avian influenza viruses comprises the following steps:
[0007] (1) using different subtypes of avian influenza virus hemagglutinin monoclonal antibodies (hybridoma cells) to prepare monoclonal antibody ascites, that is, injecting hybridoma cells of different subtypes of avian influenza virus hemagglutinin monoclonal antibodies into the peritoneal cavity of mice, collecting ascites, and then purifying the collected ascites by bag dialysis and DEAE-fiber column method to obtain monoclonal antibody ascites;
[0008] (2) preparing a mixed sample and conducting a preliminary identification to obtain a sample to be tested;
[0009] (3) using HI to measure the titer of the monoclonal antibody ascites prepared in step (1), and making a 2-fold dilution of the monoclonal antibody ascites;
[0010] (4) mixing the monoclonal antibody ascites obtained after 2-fold dilution in step (3) with the test sample obtained in step (2), shaking and mixing, and then placing at 37° C. for 20 minutes to allow the test sample to react with the monoclonal antibodies of different dilutions;
[0011] (5) Dilute the reaction solution obtained after the neutralization reaction in step (4) using the endpoint dilution method. Select 10 -1 and 10 -2 Two dilutions were inoculated into two 10-day-old SPF chicken embryos, with an inoculation volume of 0.2 mL per embryo. After the embryos were collected, the purification effect of AIVs was tested by HI test. When the titer of each virus in the corresponding allantoic fluid was higher than 2 when the monoclonal antibody was used for HI test, the virus was purified by HI test. 4 When the virus is purified, the monoclonal antibody ascites obtained by diluting the virus 2-fold in step (3) is added to the sample for neutralization until the virus is purified as shown by the HI test. The virus is then diluted and passaged once more to obtain the purified virus. The virus purification effect is then tested by the HI test.
[0012] Preferably, the subtype avian influenza virus in step (1) is one or more of the subtype avian influenza virus of H9, H3, H6 or H4.
[0013] Preferably, the mixed sample prepared in step (2) is the embryonic half infectious dose (EID) of three AIV strains (A / chicken / Guangxi / 449C11 / 2021 (H9N2), A / duck / Guangxi / 438D31 / 2021 (H6N8), A / pigeon / Guangxi / 288P43 / 2017 (H3N6))) that have been sequenced and verified correctly. 50 ) was measured: the virus was diluted 10 times with the tetra-antibody solution and inoculated into the allantoic cavity of 10-day-old SPF chicken embryos, 0.2 mL per piece, and the chicken embryos that died 24-120 hours after inoculation and those that survived 120 hours after inoculation were collected, and the infected positive embryos were counted and the EID was calculated using the Reed-Muench method 50; The titers of the three strains of virus were adjusted to 10 respectively using the allantoic fluid of 10-day-old chicken embryos that had not been inoculated with the virus. 6 EID 50 ; The first group took 0.2 mL of H9N2 and H6N8 and mixed them evenly, and the second group took 0.2 mL of H9N2, H6N8 and H3N6 and mixed them evenly. The allantoic fluids of the two groups were diluted 10 times with the four-antibody solution, and 10 -3 , 10 -4 and 10 -5 Three dilutions are inoculated into the allantoic cavity of 10-day-old SPF chicken embryos respectively, and each dilution is inoculated with 5 chicken embryos, 0.2mL for each embryo, and the allantoic fluids of dead chicken embryos and 120 hours of surviving chicken embryos inoculated for 24-120 hours are collected respectively (if all chicken embryos all died in 24 hours, several allantoic fluids are selected and collected, the same below); The allantoic fluid of the lowest dilution is selected to carry out hemagglutination inhibition test (HI) with anti-H1-H16, EDS and NDV positive serum, and the NA subtype of the AIVs in the allantoic fluid is identified with RT-PCR simultaneously, and it is identified that the first group has H9N2 and H6N8, and the second group has H9N2, H6N8 and H3N6, namely the artificial mixed sample of the first group and the artificial mixed sample of the second group are obtained respectively.
[0014] Preferably, in step (3), PBS is used as the diluent to dilute the monoclonal antibody ascites.
[0015] Preferably, in step (3), the H9 subtype is diluted at multiples of 1:32, 1:64, 1:128, and 1:256, and the H3 subtype is diluted at multiples of 1:8, 1:16, 1:32, and 1:64; other subtypes are appropriately diluted according to the HI titer of the monoclonal antibody ascites.
[0016] Preferably, the monoclonal antibody ascites in step (4) is mixed with the sample to be tested obtained in step (2) at a volume ratio of 1:1.
[0017] The virus obtained by purifying the single virus purification method in the mixed infection of multiple subtypes of avian influenza viruses described above is identified with higher accuracy than the traditional limiting dilution and serum neutralization methods.
[0018] Compared with the prior art, the present invention has the following beneficial effects:
[0019] The method of the present invention enables the relative quantitative neutralization of the monoclonal antibody and the virus, minimizes the dosage of the monoclonal antibody and the virus, makes the neutralization reaction more sensitive and accurate, saves cost and purification time, maintains the original biological characteristics of the virus, and detects and identifies the virus obtained after purification by the present invention, and the accuracy of the identification result is indeed higher than that of the single factor serum method; further, the monoclonal antibody used in the method of the present invention has strong specificity, is better than the specific serum (with relatively complex components), does not cross-react, accelerates the virus purification speed, reduces the number of virus passages, and is conducive to maintaining the biological characteristics of the virus itself. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 This is the electrophoresis diagram of NA subtypes in the allantoic fluid of Group 1 analyzed by RT-PCR; where M is DNAMaker DL1000, 1 is the N8 subtype target gene, 2 is the N2 subtype target gene, and 3 is the blank control.
[0021] Figure 2 This is the electrophoresis diagram of NA subtypes in the allantoic fluid of the second group analyzed by RT-PCR; wherein, M is DNAMaker DL1000, 1 is the N8 subtype target gene, 2 is the N2 subtype target gene, 3 is the N6 subtype target gene, and 4 is the blank control.
[0022] Figure 3 This is the electrophoresis diagram of the purification effect of group 1 in RT-PCR analysis; wherein, M is DNA MakerDL1000, 1 is the N1 subtype target gene, 2 is the N2 subtype target gene, 3 is the N3 subtype target gene, 4 is the N4 subtype target gene, 5 is the N5 subtype target gene, 6 is the N6 subtype target gene, 7 is the N7 subtype target gene, 8 is the N8 subtype target gene, and 9 is the N9 subtype target gene.
[0023] Figure 4 This is the electrophoresis diagram of the purification effect of the second group in RT-PCR analysis; wherein, M is DNA MakerDL1000, 1 is the N1 subtype target gene, 2 is the N2 subtype target gene, 3 is the N3 subtype target gene, 4 is the N4 subtype target gene, 5 is the N5 subtype target gene, 6 is the N6 subtype target gene, 7 is the N7 subtype target gene, 8 is the N8 subtype target gene, and 9 is the N9 subtype target gene. DETAILED DESCRIPTION
[0024] The following drawings are described in detail in conjunction with specific embodiments, but it should be understood that the scope of protection of the present invention is not limited by the specific embodiments. Unless otherwise specified, the raw materials and reagents used in the examples are all commercially available. Low pathogenic strains (A / chicken / Guangxi / 449C11 / 2021 (H9N2), A / duck / Guangxi / 438D31 / 2021 (H6N8), A / pigeon / Guangxi / 288P43 / 2017 (H3N6)), respectively referred to as: H9N2, H6N8 and H3N6, were separated, purified, identified and preserved by the Key Laboratory of Veterinary Biotechnology, Guangxi Zhuang Autonomous Region Veterinary Research Institute. SPF chicken embryos were purchased from Beijing Boehringer Ingelheim Weitong Biotechnology Co., Ltd.; 6-8 week old Balb / c mice were purchased from Changsha Tianqin Biotechnology Co., Ltd.
[0025] The monoclonal antibodies (hybridoma cells) of AIV hemagglutinin of H3 or H9 subtype were developed and preserved by the Guangxi Zhuang Autonomous Region Veterinary Research Institute. The preparation method referred to "Preparation and identification of monoclonal antibodies to H9 subtype influenza virus hemagglutinin" by Deng Xianwen et al. and "Production and identification of monoclonal antibodies and development of a sandwich ELISA for detection of the H3-subtype avianinfluenza virus antigen" by Luo Sisi et al.
[0026] A PBS solution containing four antibiotics was prepared in a concentration ratio of penicillin 10000 U / mL, streptomycin 10 mg / mL, gentamicin 250 μg / mL, and nystatin 5000 U / mL, referred to as "four-antibiotic solution" in the examples.
[0027] DNA / RNA co-extraction kit and DNA Marker were purchased from Beijing Quanshijin Biotechnology Co., Ltd.; reagents including M-MLV, random primers, dNTP and RNase inhibitor were purchased from Bao Bio (Beijing) Co., Ltd.; other reagents were purchased from commercial companies. PCR instrument was purchased from Bio-Rad Laboratories, USA; ultra-micro spectrophotometer was purchased from Thermo, USA.
[0028] Example 1
[0029] A method for purifying a single virus in a mixed infection of multiple subtypes of avian influenza viruses, the operating steps are as follows:
[0030] (1) Using H9 or H3 subtype AIV hemagglutinin monoclonal antibody (hybridoma cell) to prepare monoclonal antibody ascites, i.e., injecting 0.5 ml of pristane into the peritoneal cavity of mice, implanting cells within 1 to 9 weeks after injection, collecting hybridoma cells in the logarithmic growth phase, washing once with 5% FCS-1640 solution (1640 culture medium containing 5% fetal bovine serum), and centrifuging at 1000 r / min for 10 min;
[0031] Samples were taken and stained with trypan blue. The number of live cells was counted and the cells were reconstituted with 5% FCS-1640 solution to 1.0×10 7 cells / ml suspension, and mice injected with pristane were inoculated with H9 or H3 hybridoma cells. Each mouse was intraperitoneally injected with 1 ml (containing 1.0×10 7 cells / ml), the tumor volume is the largest about 10 days after inoculation, at this time, ascites can be extracted from the abdominal cavity, once every 1 to 3 days, and can be extracted 10 times;
[0032] The collected mouse ascites was dialyzed using a dialysis bag and purified by passing through a DEAE-cellulose column to obtain monoclonal antibody ascites;
[0033] (2) Preparation of mixed samples: The embryonic half infectious dose (EID) of the three AIV strains verified by sequencing (A / chicken / Guangxi / 449C11 / 2021(H9N2), A / duck / Guangxi / 438D31 / 2021(H6N8), and A / pigeon / Guangxi / 288P43 / 2017(H3N6)) was measured. 50 ) was measured: the virus was diluted 10 times with the tetra-antibody solution and inoculated into the allantoic cavity of 10-day-old SPF chicken embryos, 0.2 mL per piece, and the chicken embryos that died 24-120 hours after inoculation and those that survived 120 hours after inoculation were collected, and the infected positive embryos were counted and the EID was calculated using the Reed-Muench method 50 ; The titers of the three strains of virus were adjusted to 10 respectively using the allantoic fluid of 10-day-old chicken embryos that had not been inoculated with the virus. 6 EID 50 ; Group 1 took 0.2 mL each of H9N2 and H6N8 and mixed them evenly; Group 2 took 0.2 mL each of H9N2, H6N8 and H3N6 and mixed them evenly. The allantoic fluids of both groups were diluted 10 times with the four-antibody solution, and 10 -3 , 10 -4 and 10 -5Three dilutions are inoculated into the allantoic cavity of 10 age in days SPF chicken embryos respectively, and each dilution is inoculated into 5 chicken embryos, and every embryo 0.2mL collects the dead chicken embryos in the back 24-120 hour and the alive chicken embryo allantoic fluids in 120 hours (if all chicken embryos all died in 24 hours, then select several and collect allantoic fluids, the same below) respectively; The allantoic fluid of selecting minimum dilution to carry out hemagglutination inhibition test (HI) with anti-H1-H16, EDS and NDV positive serum, identify the NA hypotype of the AIVs in the allantoic fluid with RT-PCR simultaneously, identify that the 1st group has H9N2 and H6N8, the 2nd group has H9N2, H6N8 and H3N6, promptly obtain the artificial mixed sample of the 1st group and the artificial mixed sample of the 2nd group respectively;
[0034] (3) Using HI to determine the titer of the monoclonal antibody ascites prepared in step (1), the monoclonal antibody ascites was diluted 2-fold, using PBS as the diluent, and the purified and identified monoclonal antibody ascites was used for subsequent single virus purification; if the HI result of H9 in group 1 is determined to be 2 8 , the HI result of H9 in group 2 was judged to be 2 8 , the HI result of H3 is judged to be 2 6 , then the H9 subtype AIV monoclonal antibody is based on the HI of 2 8 The results were analyzed by PBS for 2-fold dilution, and the dilution multiples were 1:32, 1:64, 1:128, and 1:256; the H3 subtype AIV monoclonal antibody was diluted according to the HI of 2 6 The results were obtained by 2-fold dilution with PBS, and the dilution multiples were 1:8, 1:16, 1:32, and 1:64 (refer to Tables 1 and 2 for the dilution method);
[0035] Table 1 Operation formula of 2-fold dilution of monoclonal antibody of H9 subtype AIV (unit: mL)
[0036]
[0037] Table 2H3 subtype AIV monoclonal antibody 2-fold dilution operation formula (unit: mL)
[0038]
[0039] (4) The artificial mixed sample of the first group and the artificial mixed sample of the second group obtained in step (2) are respectively injected into the allantoic cavity of 10-day-old SPF chicken embryos for proliferation, and the HA titers of the two groups of artificially prepared mixed samples after proliferation are measured by hemagglutination test (HA), and four units of virus liquid (four units of virus is a unit of the amount of virus commonly used in hemagglutination test based on the amount of virus, and 25 microliters of virus antigen liquid must contain 4 agglutination units) of the two groups are configured as antigens according to the HA titer;
[0040] For group 1, 0.1 mL of the four H9 subtype AIV monoclonal antibodies of different dilutions diluted 2-fold in step (3) are taken respectively and mixed with 0.1 mL of the prepared four-unit virus solution corresponding to group 1 in a seed virus tube, and the mixture is shaken and mixed on a micro-oscillator for 1 minute and then placed at 37°C for 20 minutes to allow the sample to be tested (i.e., the artificially mixed sample) to react with the monoclonal antibodies of different dilutions to neutralize each other;
[0041] For the second group, 0.1 mL of the four H9 subtype AIV monoclonal antibodies with different dilutions after the 2-fold dilution in step (3) and the four H3 subtype AIV monoclonal antibodies with different dilutions are taken respectively and mixed thoroughly in the seed tube, and then 0.1 mL of the four-unit virus solution corresponding to the second group is added to each of the four mixing tubes. After oscillation and mixing for 1 minute, the mixture is placed at 37°C for 20 minutes to allow the sample to be tested (i.e., the artificial mixed sample) to react with the monoclonal antibodies with different dilutions. The operation method is shown in Tables 3 and 4:
[0042] Table 3 Operational procedures for mixing four different dilutions of H9 subtype AIV monoclonal antibodies with four units of virus solution after dilution in Group 1 (unit: mL)
[0043]
[0044]
[0045] Table 4 Operation procedure for mixing monoclonal antibodies of different dilutions with four units of virus solution after dilution in Group 2 (unit: mL)
[0046]
[0047] (5) After the four units of virus solution in each group were reacted with monoclonal antibodies of different dilutions, the reaction solution obtained after the neutralization reaction in step (4) was diluted by the endpoint dilution method (see Table 5 for the dilution method). 10 -1 and 10 -2 Two dilutions were inoculated into two 9-day-old SPF chicken embryos, with an inoculation volume of 0.2 mL per embryo. After the embryos were collected, the purification effect of AIVs was tested by HI test. When the titer of each virus in the corresponding allantoic fluid was higher than 2 when the monoclonal antibody was used for HI test, the virus was purified by HI test. 4 When the virus is purified, the monoclonal antibody ascites obtained by diluting the virus 2-fold in step (3) is added to neutralize the virus until the HI test proves that the virus has been purified. Then the virus is purified by diluting the virus once more. Then the HI test is used to detect the virus purification effect.
[0048] Table 5 10-fold dilution procedure of virus solution after neutralization (unit: mL)
[0049]
[0050] The virus purification effect of Example 1 was detected by HI test and RT-PCR. After confirming that it was a single subtype AIV virus liquid, nucleic acid was extracted from the purified virus liquid and sent to the second generation sequencing for verification.
[0051] The primers N1, N2, N6, N8, N3, N4, N5, N7 and N9 used in RT-PCR were referenced to primers published by others; the primer sequences are shown in Table 6. The above primers were synthesized by Thermo Fisher Guangzhou Branch.
[0052] Table 6 Nucleotide sequences of primers N1 to N9
[0053]
[0054] Example 2
[0055] (2) Collecting mixed samples: Collect throat and cloaca swab samples from poultry from live poultry markets or poultry farms, then inoculate the samples into 10-day-old SPF chicken embryos for virus proliferation, and then perform hemagglutination (HA) and hemagglutination inhibition (HI) tests to preliminarily determine whether there is mixed infection with H9, H3 or other subtypes of avian influenza virus;
[0056] In the actual detection process, step (2) is as described above, and the remaining operations are the same as in Example 1.
[0057] Practical application of the purification and identification method: In order to analyze the subtype distribution of AIVs in poultry in Guangxi Zhuang Autonomous Region, the hemagglutinin monoclonal antibody relative quantitative neutralization method of specific single subtype AIV established by the present invention was used to purify 80 HI test positive samples of avian influenza viruses separated from poultry in recent years (all collected in Guangxi Zhuang Autonomous Region) (allantoic fluid after SPF chicken embryo proliferation inoculated with throat and cloaca cotton swabs, and preliminary identification of mixed infection with H3 or H9 subtype AIV), and the obtained AIVs were identified by RT-PCR and HI test for the purification effect of the virus.
[0058] result:
[0059] 2.1 Preparation of monoclonal antibody ascites
[0060] The HI titers of purified H9 and H3 monoclonal antibodies in ascites were 2 10 and 2 7 This indicates that the HI titers of H9 and H3 monoclonal antibodies prepared using ascites are very high, meet the requirements for monoclonal antibody preparation, and can be used for subsequent experiments.
[0061] 2.2 Artificial preparation and identification of samples infected with multiple subtypes of AIVs
[0062] RNA was extracted from the artificial mixed sample (mixed infection virus solution of multiple subtypes of AIVs) prepared in step (2) of Example 1 and reverse transcribed into cDNA. The NA subtypes in the two groups of virus solutions were identified by PCR using NA primers. The results of identifying the artificially prepared mixed infection samples of multiple subtypes of AIVs are as follows: Figure 1 and Figure 2 The results showed that group 1 was a mixture of N8 and N2 subtypes; group 2 was a mixture of N8, N6 and N2 subtypes. It can be seen that the artificial preparation of two samples of mixed infection of multiple subtypes of AIVs was successful.
[0063] 2.3 Relative quantitative neutralization of AIVs in purified samples by monoclonal antibodies against hemagglutinin specific for a single subtype of avian influenza virus
[0064] According to steps (2), (3), (4) and (5) of Example 1, the two groups of allantoic fluid samples were purified respectively, and the virus purification effect was detected by HI test. The results showed (Table 3) that the H6N8 subtype AIVs of the first group of samples were purified in the second generation (E1), and the H6N8 subtype AIVs of the second group of samples were purified in the third generation (E2). After two more passages and identification, the RT-PCR and second generation sequencing results proved that the samples had been purified (Tables 7 and 8). Figure 3 , Figure 4 ).
[0065] Table 7 HI test to detect the purification of AIVs
[0066]
[0067]
[0068] 2.4 Practical application of purification and identification methods
[0069] In the process of purifying 80 samples, it was found that more than 60% of the samples were samples of mixed infection of 2 or more subtypes of AIVs, or samples of mixed infection of AIVs and Newcastle disease virus (NDV). Using the method of the present invention, i.e., the relative quantitative neutralization method of hemagglutinin monoclonal antibody of specific single subtype avian influenza virus, 15 strains of AIVs of 6 subtypes, including H1N2, H3N8, H4N6, H6N8, H11N8 and H11N3, and 9 strains of NDV were purified from 80 samples. However, when the same samples were purified by the method of preparing single factor serum neutralization, only 3 strains of H9N2 subtype AIV were purified. The number of passages of virus purification showed that the method of single factor serum neutralization and the relative quantitative neutralization method of monoclonal antibody should be increased by 2 to 3 generations, and the sequencing identification results also showed that there were more mixed viruses in the samples purified by the method of single factor serum neutralization.
[0070] Table 8 Subtypes and quantities of AIVs purified by the present invention
[0071]
[0072] The foregoing description of specific exemplary embodiments of the present invention is for the purpose of illustration and demonstration. These descriptions are not intended to limit the present invention to the precise form disclosed, and it is clear that many changes and variations can be made based on the above teachings. The purpose of selecting and describing the exemplary embodiments is to explain the specific principles of the present invention and its practical application, so that those skilled in the art can realize and utilize various different exemplary embodiments of the present invention and various different selections and changes. The scope of the present invention is intended to be limited by the claims and their equivalents.
Claims
1. A method for purifying a single virus in a mixed infection of multiple subtypes of avian influenza viruses, characterized in that: The following steps are included: (1) Using monoclonal antibodies against hemagglutinin of different subtypes of avian influenza virus to prepare monoclonal antibody ascites; (2) preparing a mixed sample and conducting a preliminary identification to obtain a sample to be tested; (3) using HI to measure the titer of the monoclonal antibody ascites prepared in step (1), and diluting the monoclonal antibody ascites; (4) mixing the monoclonal antibody ascites obtained after 2-fold dilution in step (3) with the test sample obtained in step (2), shaking and mixing, and then placing at 37° C. for 20 minutes to allow the test sample to react with the monoclonal antibodies of different dilutions; (5) Dilute the reaction solution obtained after the neutralization reaction in step (4) using the endpoint dilution method. Select 10 -1 and 10 -2 Two SPF chicken embryos were inoculated at two dilutions respectively; after the embryos were collected, the purification effect of AIVs was tested by HI test generation by generation. When the titer of each virus in the corresponding allantoic fluid was higher than 2 when the monoclonal antibody was used for HI test, 4 When the virus is purified, continue to add the monoclonal antibody ascites obtained by 2-fold dilution in step (3) to neutralize the virus until the HI test proves that the virus has been purified. Then dilute and passage once more to obtain the virus.
2. The method for purifying a single virus in a mixed infection of multiple subtypes of avian influenza viruses according to claim 1, characterized in that: The subtype avian influenza virus described in step (1) is one or more of the subtype avian influenza virus of H9, H3, H6 or H4.
3. The method for purifying a single virus in a mixed infection of multiple subtypes of avian influenza viruses according to claim 1, characterized in that: The mixed sample prepared in step (2) is the embryonic infection dose (EID) of the three AIV strains (A / chicken / Guangxi / 449C11 / 2021 (H9N2), A / duck / Guangxi / 438D31 / 2021 (H6N8), A / pigeon / Guangxi / 288P43 / 2017 (H3N6))) that were verified by sequencing. 50 ) was measured: the virus was diluted 10 times with the tetra-antibody solution and inoculated into the allantoic cavity of 10-day-old SPF chicken embryos, 0.2 mL per piece, and the chicken embryos that died 24-120 hours after inoculation and those that survived 120 hours after inoculation were collected, and the infected positive embryos were counted and the EID was calculated using the Reed-Muench method 50 ; The titers of the three strains of virus were adjusted to 10 respectively using the allantoic fluid of 10-day-old chicken embryos that had not been inoculated with the virus. 6 EID 50 ; The first group took 0.2 mL of H9N2 and H6N8 and mixed them evenly, and the second group took 0.2 mL of H9N2, H6N8 and H3N6 and mixed them evenly. The allantoic fluids of the two groups were diluted 10 times with the four-antibody solution, and 10 -3 , 10 -4 and 10 -5 Three dilutions are inoculated into the allantoic cavity of 10-day-old SPF chicken embryos respectively, and each dilution is inoculated with 5 chicken embryos, 0.2mL for each embryo, and the allantoic fluid of dead chicken embryos and 120 hours of surviving chicken embryos inoculated for 24-120 hours is collected respectively (if all chicken embryos all died in 24 hours, several allantoic fluids are selected and collected, the same below); The allantoic fluid of the lowest dilution is selected to carry out hemagglutination inhibition test (HI) with anti-H1-H16, EDS and NDV positive serum, and the NA subtype of the AIVs in the allantoic fluid is identified with RT-PCR simultaneously, and it is identified that the first group has H9N2 and H6N8, and the second group has H9N2, H6N8 and H3N6, namely the artificial mixed sample of the first group and the artificial mixed sample of the second group are obtained respectively.
4. The method for purifying a single virus in a mixed infection of multiple subtypes of avian influenza viruses according to claim 1, characterized in that: In step (3), PBS is used as a diluent to dilute the monoclonal antibody ascites.
5. The method for purifying a single virus in a mixed infection of multiple subtypes of avian influenza viruses according to claim 1, characterized in that: In step (3), the H9 subtype was diluted at multiples of 1:32, 1:64, 1:128, and 1:256, and the H3 subtype was diluted at multiples of 1:8, 1:16, 1:32, and 1:64; other subtypes were appropriately diluted according to the HI titer of the monoclonal antibody ascites.
6. The method for purifying a single virus in a mixed infection of multiple subtypes of avian influenza viruses according to claim 1, characterized in that: The monoclonal antibody ascites in step (4) is mixed with the sample to be tested obtained in step (2) at a volume ratio of 1:1.
